Advanced Biomedical Technologies (OTCMKTS:ABMT) & Bone Biologics (OTC:BBLG) Head-To-Head Contrast
Advanced Biomedical Technologies (OTCMKTS:ABMT) & Bone Biologics (OTC:BBLG) Head-To-Head Contrast
Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) and Bone Biologics (OTC:BBLG – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation.
Advanced Biomedical Technologies（OTCMKTS: ABMT — 獲取評級）和Bone Biologics（OTC: BBLG — 獲取評級）都是小型醫療公司，但哪家企業更好？我們將根據兩家公司的盈利能力、機構所有權、收益、風險、分析師建議、股息和估值對比這兩家公司。
Profitability
盈利能力
This table compares Advanced Biomedical Technologies and Bone Biologics' net margins, return on equity and return on assets.
該表比較了Advanced Biomedics和Bone Biologics的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Advanced Biomedical Technologies | N/A | N/A | N/A |
| Bone Biologics | N/A | -27.03% | -23.34% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| 先進的生物醫學技術 | 不適用 | 不適用 | 不適用 |
| 骨生物製劑 | 不適用 | -27.03% | -23.34% |
Risk & Volatility
風險與波動性
Advanced Biomedical Technologies has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Bone Biologics has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500.
Advanced BiomedicalTechnologies的beta值爲0.68，這表明其股價的波動性比標準普爾500指數低32％。相比之下，Bone Biologics的beta值爲0.75，這表明其股價的波動性比標準普爾500指數低25％。
Institutional & Insider Ownership
機構和內部所有權
7.6% of Bone Biologics shares are held by institutional investors. 34.1% of Advanced Biomedical Technologies shares are held by insiders. Comparatively, 71.5% of Bone Biologics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
7.6％的Bone Biologics股票由機構投資者持有。34.1％的Advanced Biologics股票由內部人士持有。相比之下，Bone Biologics的71.5％股票由內部人士持有。強大的機構所有權表明大型基金經理、捐贈基金和對沖基金認爲，從長遠來看，股票的表現將優於市場。
Valuation & Earnings
估值與收益
This table compares Advanced Biomedical Technologies and Bone Biologics' top-line revenue, earnings per share (EPS) and valuation.
該表比較了Advanced Biomedics和Bone Biologics的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Advanced Biomedical Technologies | $120,000.00 | 26.59 | -$670,000.00 | N/A | N/A |
| Bone Biologics | N/A | N/A | -$1.49 million | N/A | N/A |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| 先進的生物醫學技術 | 120,000.00 美元 | 26.59 | -670,000.00 美元 | 不適用 | 不適用 |
| 骨生物製劑 | 不適用 | 不適用 | -149 萬美元 | 不適用 | 不適用 |
Advanced Biomedical Technologies has higher revenue and earnings than Bone Biologics.
先進的生物醫學技術的收入和收益高於Bone Biologics。
Analyst Ratings
分析師評級
This is a breakdown of recent ratings and target prices for Advanced Biomedical Technologies and Bone Biologics, as provided by MarketBeat.com.
這是Marketbeat.com提供的先進生物醫學技術和Bone Biologics最近的評級和目標價格的明細。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Advanced Biomedical Technologies | 0 | 0 | 0 | 0 | N/A |
| Bone Biologics | 0 | 0 | 1 | 0 | 3.00 |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| 先進的生物醫學技術 | 0 | 0 | 0 | 0 | 不適用 |
| 骨生物製劑 | 0 | 0 | 1 | 0 | 3.00 |
Bone Biologics has a consensus price target of $2.25, suggesting a potential upside of 765.38%. Given Bone Biologics' higher possible upside, analysts clearly believe Bone Biologics is more favorable than Advanced Biomedical Technologies.
Bone Biologics的共識目標股價爲2.25美元，表明潛在的上漲空間爲765.38％。鑑於Bone Biologics可能有更高的上行空間，分析師顯然認爲Bone Biologics比先進的生物醫學技術更有利。
Summary
摘要
Bone Biologics beats Advanced Biomedical Technologies on 5 of the 9 factors compared between the two stocks.
與兩隻股票相比，Bone Biologics在9個因素中有5個擊敗了先進生物醫學技術。
About Advanced Biomedical Technologies
關於先進的生物醫學技術
(Get Rating)
（獲取評級）
Advanced BioMedical Technologies, Inc. engages in the provision of medical and pain management tools. Its products include Electro-Acuscope 85P (Portable), Electro-Acuscope 80L, Neuroscope 230B, Electro-Myopulse 75L (Base Model), Electro-Myopulse 75F (Used in Fermi Lab Study), and Electro-Myopulse EMS 85P (Portable). The company was founded in 1984 and is headquartered in New York, NY.
Advanced BioMedial Technologies, Inc. 從事醫療和疼痛其產品包括 Electro-Acuscope 85P（便攜式）、Electro-Acuscope 80L、Neuroscope 230B、Electro-Myopulse 75L（基本型號）、Electro-Myopulse 75F（用於費米實驗室研究）和 Electro-Myopulse EMS 85P（便攜式）。該公司成立於1984年，總部位於紐約州紐約。
About Bone Biologics
關於 Bone Biologics
(Get Rating)
（獲取評級）
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Bone Biologics Corporation是一家醫療器械公司，專注於使用重組人蛋白在脊柱融合中的骨再生。該公司的NELL-1/DBX是一種組合產品，它是一種骨刺激性重組蛋白，可爲骨再生提供靶向特異性控制。它正在開發 NELL-1/DBX 融合設備，用於治療骨骼成熟的椎間盤退行性疾病患者，其水平與 L4-S1 相同。該公司的平臺技術已應用於在脊柱、骨科、普通骨科、整形重建、神經外科、介入放射學和運動醫學等外科專業領域提供增強的療效。它與加州大學洛杉磯分校技術開發小組簽訂了許可協議，用於脊柱融合應用的 NELL-1 的開發和商業化。該公司成立於 2004 年，總部位於馬薩諸塞州伯靈頓。
Receive News & Ratings for Advanced Biomedical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Biomedical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收先進生物醫學技術的新聞和收視率 -在下面輸入您的電子郵件地址，以通過Marketbeat.com的免費每日電子郵件時事通訊接收Advanced Biomedical Technologies和相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。